Pfizer Share Price | Pfizer Stock Screener
PFIZER
Pharmaceuticals
Share Price NSE
₹4623.60
▼
-28.80 (-0.62%)
Share Price BSE
₹4617.70
▼
-32.90 (-0.71%)
As of July 24, 2026, the Pfizer share price (NSE: PFIZER) is ₹4,623.60 on NSE and ₹4,617.70 on BSE, down 0.62% from the previous close, with shares trading between ₹4,554.00 and ₹4,648.70, and a 52-week range of ₹4,404.90–₹5,766.50.
Analyse PFIZER share price data and track historical price performance.
Use the Pfizer stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Pfizer Market Cap
₹20,902.14 Cr.
PFIZER P/E Ratio (TTM)
29.39
Pfizer P/B Ratio
5.05
EPS (TTM)
₹157.92
Dividend Yield
1.62%
Debt to Equity
0.02
PFIZER 52 Week High
₹5766.50
Pfizer 52 Week Low
₹4404.90
Operating Margin
36.00%
Profit Margin
26.66%
PFIZER Revenue (TTM)
₹2,708.00
EBITDA
₹1,092.00
Net Income
₹722.00
Total Assets
₹4,922.00
Total Equity
₹4,203.00
Pfizer Share Price Chart
Screen Pfizer share price with an interactive chart. Analyse PFIZER price trends and volatility across different timeframes.
Pfizer Company Profile - Fundamental Screener
Screen Pfizer company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PFIZER shares.
Pfizer Limited is an Indian pharmaceutical company engaged in manufacturing, marketing, trading, and exporting pharmaceutical products. It has a manufacturing facility in Goa and works with contract manufacturers across India. The company offers a diverse portfolio of products including vaccines, anti-infectives, cardiac medications, pain relief, maternal nutrition, gastrointestinal treatments, contraceptives,...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Pradip Shah
ISIN
INE182A01018
Website
https://www.pfizerindia.com
Pfizer Balance Sheet Screener
Screen PFIZER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 4,922 | 4,911 | 4,229 | 4,001 | 3,901 | 3,266 | 4,405 | 3,940 | 3,690 | 3,261 |
| Current Assets | 3,803 | 3,513 | 2,738 | 2,525 | 2,397 | 1,925 | 3,048 | 2,715 | 2,417 | 2,051 |
| Fixed Assets | 678 | 724 | 713 | 749 | 869 | 894 | 973 | 886 | 950 | 902 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 92 | 124 | 87 | 136 | 183 | 99 | 137 | 37 | 52 | 62 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4,203 | 4,217 | 3,596 | 3,207 | 2,864 | 2,393 | 3,396 | 3,011 | 2,683 | 2,419 |
| Share Capital | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
| Reserves & Surplus | 4,157 | 4,172 | 3,550 | 3,162 | 2,819 | 2,347 | 3,350 | 2,966 | 2,637 | 2,373 |
Pfizer Income Statement Screener - Profit & Revenue Analysis
Screen Pfizer income statement and profit fundamentals.
Analyze PFIZER quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Pfizer share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,708 | 2,454 | 2,374 | 2,526 | 2,674 | 2,320 | 2,336 | 2,249 | 2,083 | 2,067 | 2,103 | 1,921 |
| Expenses | 1,616 | 1,541 | 1,558 | 1,616 | 1,775 | 1,526 | 1,579 | 1,516 | 1,468 | 1,617 | 1,586 | 1,470 |
| EBITDA | 1,092 | 913 | 816 | 910 | 898 | 793 | 757 | 733 | 615 | 450 | 517 | 450 |
| Operating Profit % | 36.00% | 32.00% | 29.00% | 33.00% | 32.00% | 32.00% | 27.00% | 27.00% | 25.00% | 18.00% | 21.00% | 21.00% |
| Depreciation | 58 | 61 | 62 | 106 | 115 | 109 | 103 | 71 | 66 | 63 | 124 | 131 |
| Interest | 10 | 8 | 15 | 13 | 11 | 15 | 11 | 1 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 976 | 1,016 | 746 | 824 | 773 | 669 | 643 | 660 | 548 | 517 | 402 | 238 |
| Tax | 253 | 249 | 195 | 200 | 160 | 171 | 133 | 231 | 188 | 180 | 179 | 138 |
| Net Profit | 722 | 768 | 551 | 624 | 613 | 498 | 509 | 429 | 360 | 337 | 223 | 100 |
| EPS | 157.92 | 167.79 | 119.22 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | 15.26 |
Pfizer Cash Flow Screener - Liquidity Fundamentals
Screen PFIZER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 968 | 660 | 257 | 356 | 667 | 427 | 323 | 98 | 332 | 329 |
| Investing Activities | -562 | -71 | 54 | -36 | -575 | -469 | 1,530 | 35 | -238 | -250 |
| Financing Activities | -798 | -205 | -235 | -346 | -181 | -1,571 | -164 | -110 | -110 | -83 |
| Net Cash Flow | -392 | 383 | 75 | -26 | -88 | -1,613 | 1,690 | 23 | -17 | -4 |
Pfizer Shareholding Pattern Screener
See Pfizer shareholding pattern with promoter, FII, and DII holdings.
Check Pfizer promoter holding and ownership changes for PFIZER on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% |
| FII Holding | 2.81% | 1.65% | 2.18% | 2.39% | 2.60% | 2.71% | 3.33% | 3.22% |
| DII Holding | 16.89% | 17.80% | 17.10% | 17.23% | 17.10% | 17.05% | 15.33% | 15.84% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.87% | 12.04% | 12.34% | 12.02% | 12.08% | 11.93% | 12.90% | 12.55% |
| Other Holding | 4.51% | 4.59% | 4.45% | 4.43% | 4.29% | 4.39% | 4.52% | 4.46% |
| Shareholder Count | 99,545 | 102,478 | 108,261 | 103,222 | 103,480 | 100,933 | 109,214 | 106,098 |
Pfizer Share Dividend Screener - Share Yield Analysis
Check Pfizer dividend history with payout and yield data.
View Pfizer dividend details including ex-dates and amounts for PFIZER stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹75.00 | 1.61% |
| 2025-March | ₹165.00 | 3.50% |
| 2024-March | ₹35.00 | 0.87% |
| 2023-March | ₹40.00 | 0.95% |
| 2022-March | ₹35.00 | 1.00% |
| 2021-March | ₹35.00 | 0.80% |
| 2020-March | ₹330.00 | 7.29% |
| 2019-March | ₹22.50 | 0.56% |
| 2018-March | ₹20.00 | 0.60% |
| 2017-March | ₹20.00 | 0.92% |
Pfizer Stock Index Membership
See which indices include Pfizer stock.
Check PFIZER index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP
Pfizer Market Events Screener - Corporate Actions
Get Pfizer corporate actions including splits, bonuses, and buybacks.
Check Pfizer stock events that may affect PFIZER share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-28 | 2026-07-28 | Quarterly Result Announcement | NA | 1.67% |
| 2026-07-28 | 2026-07-28 | Annual General Meeting | NA | -4.73% |
| 2026-07-17 | 2026-07-17 | Dividend | ₹ 75.00 /share | -3.64% |
| 2026-05-12 | 2026-05-12 | Quarterly Result Announcement | NA | 4.09% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -0.19% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -4.06% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.68% |
| 2025-07-21 | 2025-07-21 | Annual General Meeting | NA | 20.59% |
| 2025-07-09 | 2025-07-09 | Dividend | ₹ 30.00 /share | 32.64% |
| 2025-07-09 | 2025-07-09 | Dividend | ₹ 35.00 /share | 32.64% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 3.80% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -5.60% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -6.42% |
| 2024-08-28 | 2024-08-28 | Annual General Meeting | NA | 0.34% |
| 2024-08-21 | 2024-08-21 | Dividend | ₹ 35.00 /share | 36.12% |
Pfizer Competitors Screener - Peer Comparison
Screen PFIZER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 463,791 | 40.50 | 61,674 | 12.69% | 11,565 | 61.52 |
| Divis Laboratories | 194,336 | 76.36 | 11,067 | 13.95% | 2,568 | 73.60 |
| Torrent Pharmaceuticals | 190,081 | 89.58 | 13,886 | 20.34% | 2,138 | 66.10 |
| Cipla | 112,856 | 29.60 | 29,045 | 2.24% | 3,870 | 47.02 |
| Zydus Life Science | 111,712 | 22.00 | 27,658 | 17.64% | 5,026 | 51.92 |
| Lupin | 109,087 | 20.54 | 29,039 | 26.75% | 5,356 | 47.81 |
| Mankind Pharma | 104,979 | 54.21 | 14,636 | 14.85% | 1,938 | 55.85 |
| Dr Reddys Laboratories | 95,461 | 31.02 | 35,059 | 3.90% | 4,158 | 29.50 |
| Aurobindo Pharma | 87,417 | 25.42 | 33,385 | 3.21% | 3,376 | 49.50 |
| Laurus Labs | 85,092 | 95.73 | 6,868 | 22.01% | 890 | 64.23 |
Pfizer Company Announcements - News Screener
Screen PFIZER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-24 | Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter Ended June 30 2026. | - |
| 2026-07-21 | Response To Clarification Sought By BSE Limited. | - |
| 2026-07-21 | Clarification sought from Pfizer Ltd | - |
| 2026-07-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-07 | Letter To Shareholders Providing The Weblink To Access The Annual Report For Financial Year 2025-26. | - |
| 2026-07-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-06 | Shareholders Meeting - AGM Notice | - |
| 2026-07-06 | Reg. 34 (1) Annual Report. | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-04 | Newspaper Advertisement | - |
| 2026-06-03 | Newspaper Advertisement | - |
| 2026-05-19 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-12 | Intimation Of Date Of Annual General Meeting | - |
| 2026-05-12 | Intimation Of Record Date | - |
| 2026-05-12 | Corporate Action-Board approves Dividend | - |
| 2026-05-12 | Audited Financial Results For The Financial Year Ended March 31 2026. | - |
| 2026-05-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On May 12 2026 | - |
| 2026-05-05 | Board Meeting Intimation for Board Meeting To Consider And Approve The Financial Results For The Quarter And Year Ended March 31 2026. | - |
| 2026-04-24 | Intimation Pursuant To Regulation 30 Of SEBI LODR Regulations 2015 | - |